The results of the present study indicated that cognitive impairment is relatively prevalent (10%) in African-American patients with CHF (Generic Lasix Treating fluid build-up and swelling caused by congestive heart failure), and this prevalence increases with age. The prevalence of cognitive impairment among CHF patients has been assessed in several case-controlled studies.”  jn these studies, [...]

Continue reading " Cognitive Impairment among African-American Patients with Congestive Heart Failure: DISCUSSION "

Table 1 shows the characteristics of the study patients by cognitive impairment status. There were 36 men and 64 women (mean age 67.5 ± 9.01 years). The mean GDS score was 2.67 ±3.19. The crude prevalence of cognitive impairment (MMSE<24) was 10% and the age-adjusted prevalence was 12.5%. Thirty-nine of the study subjects were <64 [...]

Continue reading " Cognitive Impairment among African-American Patients with Congestive Heart Failure: RESULTS "

This cross-sectional sample was drawn from patients who were consecutively recruited for an ongoing, single-blinded, randomized, controlled trial evaluating the effectiveness of a telemonitoring, patient-oriented intervention to improve access to ambulatory care for heart failure patients. Eligible study subjects were African-American CHF (Generic Capoten treating high blood pressure, heart failure) patients, 55 years of age and [...]

Continue reading " Cognitive Impairment among African-American Patients with Congestive Heart Failure: METHODS "

Congestive heart failure (Generic Accupril is used for lowering high blood pressure and managing heart failure) is a major public health problem affecting over 4.7 million Americans and 15 million people worldwide. More than 550,000 new cases occur annually in the United States. Approximately 1.5-2% of the population has CHF, and the prevalence increases to [...]

Continue reading " Cognitive Impairment among African-American Patients with Congestive Heart Failure "